Greener synthesis of lignin nanoparticles and their applications

S Iravani, RS Varma - Green Chemistry, 2020 - pubs.rsc.org
The remarkable absorption capacity, biodegradability and non-toxicity of lignin
nanoparticles enable them to be appropriate vehicles for drug molecules and inorganic …

Biological activities and emerging roles of lignin and lignin-based products─ A review

F Shu, B Jiang, Y Yuan, M Li, W Wu, Y Jin… - …, 2021 - ACS Publications
Bioactive substances, displaying excellent biocompatibility, chemical stability, and
processability, could be extensively applied in biomedicine and tissue engineering. In recent …

Lignins and their derivatives with beneficial effects on human health

MP Vinardell, M Mitjans - International journal of molecular sciences, 2017 - mdpi.com
A review of the pharmacological applications of lignins provides evidence of their protective
role against the development of different diseases. In many cases, the effects of lignins could …

Lignin-derived biomaterials for drug release and tissue engineering

M Witzler, A Alzagameem, M Bergs… - Molecules, 2018 - mdpi.com
Renewable resources are gaining increasing interest as a source for environmentally
benign biomaterials, such as drug encapsulation/release compounds, and scaffolds for …

Extraction of lignin and therapeutic applications of lignin-derived compounds. A review

I Spiridon - Environmental Chemistry Letters, 2020 - Springer
Natural polymers are recognized for health improvement and, as a consequence, are widely
used in controlled drug delivery, tissue engineering, regenerative medicine, wound …

Lignin–An underutilized, renewable and valuable material for food industry

J Tao, S Li, F Ye, Y Zhou, L Lei… - Critical reviews in food …, 2020 - Taylor & Francis
Lignin is the second most abundant biorenewable polymers only next to cellulose and is
ubiquitous in various plant foods. In food industry, lignin often presented as a major …

A unique nonsaccharide mimetic of heparin hexasaccharide inhibits colon cancer stem cells via p38 MAP kinase activation

RS Boothello, NJ Patel, C Sharon, EI Abdelfadiel… - Molecular cancer …, 2019 - AACR
Targeting of cancer stem cells (CSC) is expected to be a paradigm-shifting approach for the
treatment of cancers. Cell surface proteoglycans bearing sulfated glycosaminoglycan (GAG) …

[HTML][HTML] A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding

RA Al‐Horani, EI Abdelfadiel, DK Afosah… - Journal of Thrombosis …, 2019 - Elsevier
Abstract Background Human factor XIa (FXIa) is an actively pursued target for development
of safer anticoagulants. Our long‐standing hypothesis has been that allosterism originating …

Allosteric partial inhibition of monomeric proteases. Sulfated coumarins induce regulation, not just inhibition, of thrombin

S Verespy III, AY Mehta, D Afosah, RA Al-Horani… - Scientific Reports, 2016 - nature.com
Allosteric partial inhibition of soluble, monomeric proteases can offer major regulatory
advantages, but remains a concept on paper to date; although it has been routinely …

Designing Synthetic, Sulfated Glycosaminoglycan Mimetics That Are Orally Bioavailable and Exhibiting In Vivo Anticancer Activity

S Morla, O Ravikumar, C O'Hara… - Journal of Medicinal …, 2023 - ACS Publications
Sulfated glycosaminoglycans (GAGs), or synthetic mimetics thereof, are not favorably
viewed as orally bioavailable drugs owing to their high number of anionic sulfate groups …